Approaches and Considerations for the Investigation and Synthesis of <i>N</i>-Nitrosamine Drug Substance-Related Impurities (NDSRIs)
Ian W. Ashworth, Alexander Blanazs, Jonathan J. Byrne, Olivier Dirat, Jared W. Fennell, Nadine Kuhl, Stuart L. Wells, Matthew Whiting
Abstract
N -Nitrosamine risk assessment of pharmaceuticals has moved from an initial focus on the potential presence of known small-molecule N -nitrosamines such as N -nitrosodimethylamine (NDMA) and N -nitrosodiethylamine (NDEA) in active substances toward the potential for generation of more complex nitrosamine drug substance-related impurities (NDSRIs) in drug products. While N -nitrosation of simple secondary amines is well-understood, more complex amines can undergo alternative reaction pathways that can be more challenging to predict. A number of such complex amines are known not to undergo N -nitrosation but are either unreactive or react by alternative pathways such as C -nitrosation or nitration to generate non- N -nitrosamine products. This article proposes a standard set of three orthogonal nitrosation forced degradation type reaction conditions that can be used to investigate the potential for generation of novel N -nitrosamines by nitrosation of complex amines. These complementary reaction conditions are considered to provide a thorough evaluation of the potential for N -nitrosamine formation from complex amines with respect to risk factors within pharmaceutical manufacturing. If, after investigation of nitrosation under the proposed conditions, formation and isolation of an N -nitrosamine is not possible, the resultant understanding of chemical reactivity and stability can be used to justify that the N -nitrosamine in question would not be expected to be generated from the complex amine in the drug substance or product. If an N -nitrosamine is formed under these reaction conditions, the information gained can be used as part of the risk assessment and also provides a starting point for the development of a process to synthesize a discrete sample for further testing. Additionally, synthetic and analytical considerations that should be taken into account during preparation of novel N -nitrosamines for use in analytical or toxicological studies are discussed.